Continued Dexamethasone at Discharge Not Tied to Better COVID-19 Outcomes
No association seen with reduced 14-day all-cause readmission or mortality for individuals continuing dexamethasone at discharge
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.